{"id":9795,"date":"2026-05-21T21:00:00","date_gmt":"2026-05-21T19:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=61004ddc8d0ff30ad9999bdeba77d8a9"},"modified":"2026-05-21T21:00:00","modified_gmt":"2026-05-21T19:00:00","slug":"openevidence-launches-voice-mode-the-first-native-speech-to-speech-medical-ai","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=9795","title":{"rendered":"OpenEvidence Launches Voice Mode: The First Native Speech-to-Speech Medical AI"},"content":{"rendered":"<p class=\"bwalignc\">\n<i>OpenEvidence becomes the first multimodal medical AI, with a native speech-to-speech interface that delivers hands-free, evidence-backed answers to doctors.<\/i><\/p><p>MIAMI--(BUSINESS WIRE)--<a href=\"https:\/\/twitter.com\/hashtag\/clinicalai?src=hash\" >#clinicalai<\/a>--OpenEvidence, the most widely used medical AI platform among U.S. physicians, today launched Voice Mode, the first native speech-to-speech medical AI interface. With Voice Mode, OpenEvidence becomes the first multimodal medical AI offering a hands-free way for clinicians to ask questions aloud, and hear cited answers read back, on the same peer-reviewed evidence base. The feature is live in the OpenEvidence web and mobile apps and is free for all users.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260521555369\/en\/2812017\/19\/speech-to-speech-final.mp4\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260521555369\/en\/2812017\/5\/speech-to-speech-final.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260521555369\/en\/2812017\/19\/speech-to-speech-final.mp4\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260521555369\/en\/2812017\/21\/speech-to-speech-final.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260521555369\/en\/2789799\/5\/OpenOvidence_Logo.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260521555369\/en\/2789799\/22\/OpenOvidence_Logo.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260521555369\/en\/2789799\/5\/OpenOvidence_Logo.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260521555369\/en\/2789799\/21\/OpenOvidence_Logo.jpg\" \/><\/a><p>\nPhysicians reach for clinical evidence on the go: between rooms, on rounds, walking the corridor outside an OR, charting one-handed during a phone call. Voice Mode is built for those moments. A clinician taps the orange waveform icon, asks a question, and hears a concise spoken answer drawn from the same sources that power OpenEvidence today, including the New England Journal of Medicine, JAMA, Cochrane, and NCCN guidelines.<\/p><p>\n\u201cThere are two sides to building a medical AI \u2014 the intelligence and the interface. We've spent years on the intelligence. With Voice Mode, we're advancing the interface to match the everyday reality of practicing medicine,\u201d said <b>Daniel Nadler, Founder and CEO <\/b>of OpenEvidence.<\/p><p>\nEvery spoken answer comes with the written transcript and underlying references in the same conversation, available the moment the clinician returns to the screen. Clinicians can interrupt mid-answer to redirect or refine the question. In noisy environments, a tap mutes the microphone until they are ready to speak again. For physicians who want voice input without a spoken response, a separate microphone icon dictates the question as text into a standard OpenEvidence search.<\/p><p>\nVoice runs on the same intelligence as the rest of OpenEvidence. Every spoken answer is drawn from a curated corpus of peer-reviewed literature and read back with the citation chain attached. A clinician can verify any claim by opening the underlying source the moment they are back at a screen. The standard for spoken answers is the standard for written ones.<\/p><p>\n\u201cWhen I\u2019m in the ED, I\u2019m never at a workstation when I actually need an answer. I\u2019m gloved, gowned, on the phone or in between patients. Voice Mode gives me the answers I need in those in-between moments,\u201d said <b>Ania Bilski, MD, VP of Clinical AI <\/b>at OpenEvidence and a practicing emergency medicine physician at UCSF and Kaiser Permanente.<\/p><p>\n\u201cVoice Mode in the clinic has a higher bar than anywhere else. When you\u2019re talking through a case and thinking out loud, you naturally pause to think and expect the AI to wait. It should just feel like a conversation with a colleague,\u201d said <b>Maya Shah<\/b>, <b>AI engineer <\/b>at OpenEvidence.<\/p><p>\nOpenEvidence now fields more than a million clinical questions a day. Voice opens that flow to the moments when those clinicians are not at a screen. Voice answers are shorter and shaped for listening; the references and the full written form remain in the conversation, so the verification standard is the same as it has always been.<\/p><p>\n<b>About OpenEvidence<\/b><\/p><p>\nOpenEvidence is the most widely used medical AI platform among U.S. physicians, and is trusted by hundreds of thousands of verified clinicians to make high-stakes clinical decisions at the point of care with answers that are sourced, cited, and grounded in peer-reviewed medical literature. OpenEvidence was founded with the mission to organize and expand the world's collective medical knowledge. Learn more at <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fopenevidence.com&amp;esheet=54539730&amp;newsitemid=20260521555369&amp;lan=en-US&amp;anchor=openevidence.com&amp;index=1&amp;md5=59c607a4d5b2213e6114e0a88b07d745\" rel=\"nofollow\" shape=\"rect\">openevidence.com<\/a>.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\nOpenEvidence\n<br\/><a  href=\"mailto:media@openevidence.com\" rel=\"nofollow\" shape=\"rect\">media@openevidence.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>OpenEvidence becomes the first multimodal medical AI, with a native speech-to-speech interface that delivers hands-free, evidence-backed answers to doctors.MIAMI&#8211;(BUSINESS WIRE)&#8211;#clinicalai&#8211;OpenEvidence, the most widely used medical AI platform amo&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9795","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/9795","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9795"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/9795\/revisions"}],"predecessor-version":[{"id":9796,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/9795\/revisions\/9796"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9795"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9795"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9795"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}